TP53 and gastric cancer: The frequencies of actionable targets (Table 4) and mutations including TP53 (33%), APC (7.4%), SMAD4 (7.4%), and PIK3CA (7.4%), were consistent with those in a cohort of 666 specimens of GC [42].